Legend Biotech LEGN
NASDAQ LEGN
$18.57 -0.75 (-3.88%)
At close: Oct 2, 2026 · 4:00 PM EDT

Legend Biotech (LEGN) Net Preferred Shares Issued and Repurchased (2020)

Updated

Legend Biotech (LEGN) reported Net Preferred Shares Issued and Repurchased of -$2.51 million for Q4 2020.

Analysis

Legend Biotech (LEGN) Net Preferred Shares Issued and Repurchased (2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Pref. Shares Issued (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Legend Biotech 3.42 Bn -317.56 Mn 251.50 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 -2.51 Mn
Sep 30, 2020 -2.26 Mn
API Access

Legend Biotech Net Preferred Shares Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-preferred-shares-issued-and-repurchased&ticker=LEGN&period=max&api_key=YOUR_API_KEY